Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chollet

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Cancer Research|October 15, 1990
Clonotypic heterogeneity in cutaneous T-cell lymphomasY J Bignon, P Souteyrand, H Roger, et al.
Anti-Cancer Drugs|August 1, 1996
Circadian variation in O6-methylguanine-DNA methyltransferase activity in mouse liverN Martineau-Pivoteau, C Cussac-Buchdahl, P Chollet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateF Levi, B Perpoint, C Garufi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancerB Chevallier, P Chollet, Y Merrouche, et al.
Bone Marrow Transplantation|November 25, 1998
Mobilization of peripheral blood progenitor cells after induction chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and granulocyte colony-stimulating factor in breast cancerS Charrier, J Chassagne, H Curé, et al.
British Journal of Cancer|June 5, 2003
Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rateS Amat, P Bougnoux, F Penault-Llorca, et al.
Journal of Neuro-Oncology|February 24, 2001
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adultsH Roche, H Cure, A Adenis, et al.
Cornea|September 19, 1997
Interleukin-6 in tear fluid after photorefractive keratectomy and its effects on keratocytes in cultureF Malecaze, V Simorre, P Chollet, et al.
Journal of the National Cancer Institute|November 2, 1994
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trialF A Lévi, R Zidani, J M Vannetzel, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acidD Machover, E Goldschmidt, P Chollet, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Cancer Research|October 15, 1990
Clonotypic heterogeneity in cutaneous T-cell lymphomasY J Bignon, P Souteyrand, H Roger, et al.
Anti-Cancer Drugs|August 1, 1996
Circadian variation in O6-methylguanine-DNA methyltransferase activity in mouse liverN Martineau-Pivoteau, C Cussac-Buchdahl, P Chollet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateF Levi, B Perpoint, C Garufi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancerB Chevallier, P Chollet, Y Merrouche, et al.
Bone Marrow Transplantation|November 25, 1998
Mobilization of peripheral blood progenitor cells after induction chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and granulocyte colony-stimulating factor in breast cancerS Charrier, J Chassagne, H Curé, et al.
British Journal of Cancer|June 5, 2003
Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rateS Amat, P Bougnoux, F Penault-Llorca, et al.
Journal of Neuro-Oncology|February 24, 2001
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adultsH Roche, H Cure, A Adenis, et al.
Cornea|September 19, 1997
Interleukin-6 in tear fluid after photorefractive keratectomy and its effects on keratocytes in cultureF Malecaze, V Simorre, P Chollet, et al.
Journal of the National Cancer Institute|November 2, 1994
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trialF A Lévi, R Zidani, J M Vannetzel, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acidD Machover, E Goldschmidt, P Chollet, et al.
Pageof 14